The Health, Education, Labor and Pensions Committee today held the first in a series of hearings on how to reduce health care costs, which will examine administrative costs and waste, how to improve transparency, private sector solutions and other issues. Witnesses at today’s hearing included representatives from the Department of Health Policy at Vanderbilt University School of Medicine, Harvard Global Health Institute, Health Care Cost Institute and Georgetown University Law Center. In a statement submitted to the committee, AHA encouraged Congress to “pursue actions that will help reduce the cost of coverage without putting access to care at risk,” including addressing the high costs of prescription drugs, regulatory and administrative burden, and chronic disease, and “promoting enrollment in comprehensive health coverage to share costs across the broadest population possible.” While the share of national health expenditures for hospital care has declined and hospital price growth remains under 2%, spending for retail and inpatient prescription drugs have surged and hospitals “continue to provide a significant amount of uncompensated care,” increasingly because “individuals who have insurance cannot meet their high deductibles and other cost-sharing requirements,” the statement notes.

Related News Articles

Headline
The Department of Health and Human Services Office of Inspector General Jan. 27 released a bulletin addressing how direct-to-consumer drug programs can sell…
Headline
The Centers for Medicare & Medicaid Services Jan. 27 announced 15 drugs under Medicare Parts D and B selected for the third round of price negotiations.…
Headline
The House Energy and Commerce Subcommittee on Health and Ways and Means Committee Jan. 22 hosted hearings on health care affordability that included…
Headline
The House Budget Committee hosted a hearing Jan. 21 on health care affordability titled, “Reverse the Curse: Skyrocketing Health Care Costs and America’s…
Headline
The White House released a health care plan Jan. 15 addressing drug prices, health insurance premiums and price transparency efforts. The plan includes…
Headline
The Department of Health and Human Services and Drug Enforcement Administration Dec. 30 released a temporary rule extending for the fourth time waiver…